# VALSARTAN; HYDROCHLOROTHIAZIDE
> **ANDA091654** · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT PHARMS LTD · Approved 2012-04-10
## Drug
- **FDA Application Number:** ANDA091654
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VALSARTAN; HYDROCHLOROTHIAZIDE
- **Generic name:** Valsartan
- **Active ingredients:** VALSARTAN; HYDROCHLOROTHIAZIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TORRENT PHARMS LTD
- **First approval:** 2012-04-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091654)
---
*MORVS · CC0 1.0*